{"cluster": 35, "subcluster": 9, "abstract_summ": "Our results indicate a positive effect of irisin on the expression of multiple genes related to viral infection in the adipose tissue; furthermore, translatable for other tissues and organs targeted by the novel coronavirus and present, thus, promising approaches for the treatment of COVID-19 infection as therapeutic strategy to decrease ACE2 regulatory genes.Although angiotensin-converting enzyme 2 (ACE2) is crucial for SARS-CoV2 to bind and enter host cells, no study has systematically assessed the ACE2 expression in the lungs of patients with these diseases.To date, no study has assessed the ACE2 expression in the lungs of patients with these diseases.Here, we analyzed over 700 lung transcriptome samples of patients with comorbidities associated with severe COVID-19 and found that ACE2 was highly expressed in these patients, compared to control individuals.Here, we analyzed over 700 lung transcriptome samples of patients with comorbidities associated with severe COVID-19 and found that ACE2 was highly expressed in these patients, compared to control individuals.", "title_summ": "ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19.Highly ACE2 Expression in Pancreas May Cause Pancreas Damage After SARS-CoV-2 InfectionACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes", "title_abstract_phrases": "ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19.PATIENTS who died from COVID-19 often had comorbidities, such as hypertension, diabetes, and chronic obstructive lung disease.Our results indicate a positive effect of irisin on the expression of multiple genes related to viral infection in the adipose tissue; furthermore, translatable for other tissues and organs targeted by the novel coronavirus and present, thus, promising approaches for the treatment of COVID-19 infection as therapeutic strategy to decrease ACE2 regulatory genes.Although angiotensin-converting enzyme 2 (ACE2) is crucial for SARS-CoV2 to bind and enter host cells, no study has systematically assessed the ACE2 expression in the lungs of patients with these diseases.Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytesObesity patients are more susceptible to develop COVID-19 severe outcome due to the role of angiotensin-converting enzyme 2 (ACE2) in the viral infection.To date, no study has assessed the ACE2 expression in the lungs of patients with these diseases."}